Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
752,073
-
Share change
-
-155,432
-
Total reported value
-
$60,990,245
-
Price per share
-
$81.13
-
Number of holders
-
75
-
Value change
-
-$12,062,440
-
Number of buys
-
24
-
Number of sells
-
43
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2021
As of 31 Dec 2021,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
752,073 shares.
The largest 10 holders included
Peak Asset Management, LLC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, UBS Group AG, Federation des caisses Desjardins du Quebec, U.S. Capital Wealth Advisors, LLC, and DUMONT & BLAKE INVESTMENT ADVISORS LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.